|
UTP11L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.907200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.881600E-01 |
| Normal-vs-Stage2 |
8.421200E-01 |
| Normal-vs-Stage3 |
1.280380E-01 |
| Normal-vs-Stage4 |
1.625540E-02 |
| Stage1-vs-Stage2 |
6.547800E-01 |
| Stage1-vs-Stage3 |
4.674300E-02 |
| Stage1-vs-Stage4 |
1.639690E-03 |
| Stage2-vs-Stage3 |
3.359800E-01 |
| Stage2-vs-Stage4 |
3.426300E-02 |
| Stage3-vs-Stage4 |
1.450800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.047400E-01 |
| Normal-vs-AfricanAmerican |
5.534200E-01 |
| Normal-vs-Asian |
1.227550E-01 |
| Caucasian-vs-AfricanAmerican |
5.934400E-01 |
| Caucasian-vs-Asian |
1.713690E-02 |
| AfricanAmerican-vs-Asian |
2.575600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.061200E-01 |
| Normal-vs-Female |
2.766500E-02 |
| Male-vs-Female |
5.316000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.690000E-01 |
| Normal-vs-Extreme_Weight |
9.089200E-01 |
| Normal-vs-Obese |
6.309600E-01 |
| Normal-vs-Extreme_Obese |
4.305600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.347200E-01 |
| Normal_Weight-vs-Obese |
9.228400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.855800E-01 |
| Extreme_Weight-vs-Obese |
6.998600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.195000E-01 |
| Obese-vs-Extreme_Obese |
4.516800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.174400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.095800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.556600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.457500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.718370E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.124060E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.355200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.455800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.926400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.819200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.608800E-01 |
| Normal-VS-Type2 PRCC |
4.050600E-01 |
| Normal-VS-KIRP CIMP |
3.75199999957943E-08 |
| Normal-VS-Unclassified PRCC |
7.244200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.728190E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.27509999994879E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
5.027000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.86095999999969E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.767200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.70659999985257E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.215600E-01 |
| Normal-vs-N1 |
1.777880E-03 |
| Normal-vs-N2 |
5.152200E-01 |
| N0-vs-N1 |
4.965900E-04 |
| N0-vs-N2 |
4.365200E-01 |
| N1-vs-N2 |
6.503000E-01 |
|
|
